GoHealth, Inc. (NASDAQ:GOCO) Receives Consensus Rating of “Hold” from Analysts

Shares of GoHealth, Inc. (NASDAQ:GOCOGet Rating) have received a consensus recommendation of “Hold” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $3.04.

A number of brokerages have issued reports on GOCO. Credit Suisse Group cut their price objective on GoHealth from $3.00 to $1.50 in a report on Thursday, March 17th. Truist Financial cut GoHealth from a “buy” rating to a “hold” rating and set a $2.00 price objective for the company. in a report on Wednesday, March 2nd. Royal Bank of Canada cut GoHealth from an “outperform” rating to a “sector perform” rating and cut their price objective for the company from $10.00 to $2.00 in a report on Thursday, March 3rd. Finally, Evercore ISI cut their price objective on GoHealth from $4.50 to $1.75 and set an “in-line” rating for the company in a report on Wednesday, March 16th.

GOCO opened at $0.58 on Thursday. GoHealth has a fifty-two week low of $0.56 and a fifty-two week high of $11.91. The company has a current ratio of 2.78, a quick ratio of 2.78 and a debt-to-equity ratio of 1.10. The firm’s fifty day moving average price is $0.74 and its two-hundred day moving average price is $1.77.

GoHealth (NASDAQ:GOCOGet Rating) last posted its quarterly earnings results on Tuesday, May 10th. The company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.03). GoHealth had a positive return on equity of 10.28% and a negative net margin of 17.78%. The business had revenue of $270.59 million for the quarter, compared to analyst estimates of $165.57 million. On average, sell-side analysts anticipate that GoHealth will post -0.23 EPS for the current fiscal year.

Several institutional investors have recently added to or reduced their stakes in GOCO. Schonfeld Strategic Advisors LLC raised its holdings in GoHealth by 409.2% during the 3rd quarter. Schonfeld Strategic Advisors LLC now owns 66,702 shares of the company’s stock worth $336,000 after purchasing an additional 53,602 shares during the last quarter. National Bank of Canada FI bought a new stake in GoHealth during the 4th quarter worth about $3,470,000. Cubist Systematic Strategies LLC raised its holdings in GoHealth by 1,276.3% during the 3rd quarter. Cubist Systematic Strategies LLC now owns 426,907 shares of the company’s stock worth $2,147,000 after purchasing an additional 395,889 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in GoHealth by 111.4% during the 3rd quarter. Goldman Sachs Group Inc. now owns 304,000 shares of the company’s stock worth $1,529,000 after purchasing an additional 160,211 shares during the last quarter. Finally, Two Sigma Advisers LP bought a new stake in GoHealth during the 3rd quarter worth about $340,000. 41.94% of the stock is owned by institutional investors and hedge funds.

GoHealth Company Profile (Get Rating)

GoHealth, Inc operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareInternal; MedicareExternal; Individual and Family Plans (IFP) and OtherInternal; and IFP and OtherExternal. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.

Featured Stories

Analyst Recommendations for GoHealth (NASDAQ:GOCO)

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.